Unknown

Dataset Information

0

Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the N-terminal carbohydrate-recognition domain of human galectin-4.


ABSTRACT: Galectin-4 is a tandem-repeat-type galectin that is expressed in the epithelium of the alimentary tract from the tongue to the large intestine. Additionally, strong expression of galectin-4 can also be induced in cancers in other tissues, including the breast and liver. In order to explore its potential as a target for anticancer drug design, elucidation of the structural basis of the carbohydrate-binding specificities of galectin-4 has been focused on. As an initial step, the N-terminal carbohydrate-recognition domain of human galectin-4 (hGal4-CRD-1) has been successfully crystallized using the vapour-diffusion technique, a complete data set has been collected to 2.2 A resolution and the structure has been solved by the molecular-replacement technique. The crystals belonged to space group P6(1)22, with unit-cell parameters a = b = 71.25, c = 108.66 A. The asymmetric unit contained one molecule of hGal4-CRD-1, with a V(M) value of 2.34 A(3) Da(-1) and a solvent content of 47.51%.

SUBMITTER: Zimbardi AL 

PROVIDER: S-EPMC2864688 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the N-terminal carbohydrate-recognition domain of human galectin-4.

Zimbardi Ana Lucia L R AL   Pinheiro Matheus P MP   Dias-Baruffi Marcelo M   Nonato M Cristina MC  

Acta crystallographica. Section F, Structural biology and crystallization communications 20100429 Pt 5


Galectin-4 is a tandem-repeat-type galectin that is expressed in the epithelium of the alimentary tract from the tongue to the large intestine. Additionally, strong expression of galectin-4 can also be induced in cancers in other tissues, including the breast and liver. In order to explore its potential as a target for anticancer drug design, elucidation of the structural basis of the carbohydrate-binding specificities of galectin-4 has been focused on. As an initial step, the N-terminal carbohy  ...[more]

Similar Datasets

| S-EPMC2443957 | biostudies-literature
| S-EPMC3943092 | biostudies-literature
| S-EPMC2688435 | biostudies-literature
| S-EPMC2664774 | biostudies-literature
| S-EPMC1978132 | biostudies-literature
| S-EPMC3087655 | biostudies-literature
| S-EPMC2864695 | biostudies-literature
| S-EPMC3412782 | biostudies-literature
| S-EPMC2219979 | biostudies-literature
| S-EPMC3212454 | biostudies-literature